SEC Form 4 · accession 0001415889-18-000918

· CELG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 7, 2018

Accepted (ET)

Jun 11, 2018 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000816284

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jun 7, 2018	M	27,750	$30.01	A	27,750	D
Common Stock^F1,F2	Jun 7, 2018	S	13,000	$78.77	D	0	D
Common Stock^F3	holding	—	—		—	116,804	I	Family Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F5,F4	$30.01	Jun 7, 2018	M	27,750	D	—	Jun 18, 2018	Common Stock	27,750	0	D

F1The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $78.77 to $78.81, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F214,750 shares were transferred to the Casey Family Trust U/A Dated 12/28/2004.
F3The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4The option was fully exercisable.
F5The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan.